The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Pathogenesis of haemophagocytic lymphohistiocytosis
Open accessAbstract
Haemophagocytic lymphohistiocytosis (HLH) is a rare, fatal disease of early infancy. The familial form of this disease was originally described by Farquhar and Claireaux (1952) and overlooked for several years. Janka (1983) detailed the main features of familial HLH in a comprehensive clinical review. Autosomal recessive inheritance has been demonstrated for familial HLH (Gencik et al, 1984). As only a limited proportion of cases have documented familial recurrence, despite similar presenting features and outcome, the term HLH is commonly used to indicate the disease in both familial or apparently sporadic cases. Its incidence has been estimated to be 0·12 per 100 000 children in a retrospective Swedish study (Henter et al, 1991a). A similar incidence was later found in a British study (cited in Henter et al, 1998). In a recent Italian study, the estimate of the incidence of HLH in the whole country over the last 25 years was 0·006 per 100 000 children per year, but in the Southern part of Italy the disease was three times more frequent than in the Northern and Central areas. Owing to the improvement in detecting HLH cases, the observed frequency of the disease has increased over time, reaching the value of 0·118 per 100 000 children per year in the last period (1990–99) (unpublished observations). The main features of HLH include persistent fever and hepatosplenomegaly. Central nervous system involvement varies (ranging from irritability to overt meningoencephalopathy), and lymphadenopathy and skin rash may also be observed (Janka, 1983; Aricòet al, 1996, Haddad et al, 1997; Henter et al, 1998). Evidence of anaemia and thrombocytopenia may suggest the existence of acute leukaemia which can easily be ruled out by bone marrow examination. The above described clinical picture, the absence of malignant cells together with the possible association with active haemophagocytosis (which may be already evident at presentation or at repeated examinations during the disease course, in the bone marrow or in the spleen, lymph nodes or cerebrospinal fluid cells; Favara, 1989; Ost et al, 1998) are highly suggestive of HLH. Biochemical alterations largely overlap with those characteristic of the macrophage hyperactivation syndrome (Ravelli et al, 1996) and include hypertriglyceridaemia, hypofibrinogenaemia, hyponatraemia, elevated ferritin and lactase dehydrogenase (LDH) levels. Cerebrospinal fluid (CSF) pleocytosis is common. Plasma levels of soluble interleukin 2 receptor (CD25) are also increased (Komp et al, 1989; Henter et al, 1991b). Clinical and laboratory markers of associated infection were reported in 50 of the 122 (41%) children reported to the HLH registry. Of these, 25 had a positive family history of HLH and their features were not significantly different from the other 25 non-familial ones, or from the 72 children (34 familial) without evidence of associated infection at presentation. The spectrum of reported infectious agents mirrored that of common pathogens, including cytomegalovirus (CMV), Epstein-Barr virus (EBV), adenovirus, parvovirus, hepatitis B virus, herpes and Coxsackie (Aricòet al, 1996; Henter et al, 1993). Histological examination of involved organs typically shows infiltration by histiocytes and lymphocytes, with haemophagocytosis (Akima & Sumi, 1984; Favara, 1989; Ost et al, 1998); spleen biopsy may also provide evidence of haemophagocytosis, but because of possible complications it should be applied with caution; liver biopsy is often less informative, showing a hepatitis-like lymphocytic infiltration. Thus, repeated bone marrow aspirations appear to be the best approach for the documentation of haemophagocytosis. Differently from the more common Langerhans' cell histiocytosis, bone and adjacent soft tissues are not involved in HLH (Favara et al, 1997; Aricò & Egeler, 1998). The spontaneous course of the disease is invariably fatal, as illustrated by the median survival of 6 months and no more than 10% probability of survival beyond 3 years reported in the historical series collected by the International HLH Registry (Aricòet al, 1996). Initial therapeutic approaches showed that etoposide, with or without steroids and intrathecal methotrexate, can induce disease remission (Ambruso et al, 1980; Fischer et al, 1985). On this basis, the HLH study group of the Histiocyte Society started an international prospective therapeutic trial named HLH-94 (Henter et al, 1997). The preliminary results of this study showed that combined immunochemotherapy with dexamethasone, etoposide and cyclosporine was effective in achieving control of the disease manifestations within a few weeks, and also in prolonging the survival (J. I. Henter personal communication). The increased incidence documented in Italy, together with current availability of such an effective treatment, probably resulted in the marked reduction of cases of HLH who died in an early stage of the disease owing to uncontrolled progression. This
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypercytokinemia in familial hemophagocytic lymphohistiocytosis
Henter, J., Elinder, G., Soder, O., Hansson, M., Andersson, B., & Andersson, U. (1991) · Blood · doi:10.1182/blood.v78.11.2918.2918 · Cited by 505
Impaired natural killer activity in lymphohistiocytosis syndrome
Perez, N., Virelizier, J.-L., Arenzana-Seisdedos, F., Fischer, A., & Griscelli, C. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80549-1 · Cited by 121 · cited 1×
“From 1984 onwards, evidence of impaired cellular cytotoxicity in HLH has been repeatedly confirmed (Perez et al, 1984; AricoÁ et al, 1988; Kataoka et al, 1990).”
Background
Cited by
Adult haemophagocytic syndrome
Ramos-Casals, M., Brito-Zerón, P., López-Guillermo, A., Khamashta, M. A., & Bosch, X. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61048-x · Cited by 1,442
Henter, J.-I. (2002) · Blood · doi:10.1182/blood-2002-01-0172 · Cited by 900
zur Stadt, U. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi076 · Cited by 562
Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan
Ishii, E., Ohga, S., Imashuku, S., Yasukawa, M., Tsuda, H., Miura, I., Yamamoto, K., Horiuchi, H., Takada, K., Ohshima, K., et al. (2007) · International Journal of Hematology · doi:10.1532/ijh97.07012 · Cited by 468
Macrophage activation syndrome
Ravelli, A. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200209000-00012 · Cited by 340
Metadata
- Authors
- Aricò, M., Danesino, C., Pende, D., & Moretta, L.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2001-09
- Volume
- 114
- Issue
- 4
- Pages
- 761-769
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2076346890
- Cited by
- 235
- References
- 2
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathogenesis of haemophagocytic lymphohistiocytosis. https://app.cochat.ai/papers/10.1046/j.1365-2141.2001.02936.x
- The paper
- Aricò, M., Danesino, C., Pende, D., & Moretta, L. (2001). Pathogenesis of haemophagocytic lymphohistiocytosis. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.2001.02936.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.